Skip to main content
. 2023 Jun 30;13:10613. doi: 10.1038/s41598-023-37214-w

Table 1.

Demographics and clinical characteristics of healthy subjects and low-teens NTG.

Healthy group (N = 32) Low-teens NTG (N = 35) P-value
Age (years) 59.6 ± 13.5 58.7 ± 14.2 0.655*
Sex (Male : Female) 15 : 17 15 : 19 0.266
Body-mass index (Kg/m2) 23.97 ± 2.51 23.63 ± 3.07 0.836*
Diabetes mellitus, n (%) 6 (18.8) 7 (20.0) 0.878
Hypertension, n (%) 9 (28.1) 11 (31.4) 0.945
No. of antihypertensive medications, n
No medication 0 1 0.534
1 medication 3 4
 ≥ 2 medications 6 6
Antihypertensive medication type
ACEIs 4 3 0.224
Angiotensin II receptor blocker 2 2
CCBs 5 5
Diuretics 2 3
BRBs 4 5
Spherical equivalent (Diopters) -1.05 ± 2.32 -1.75 ± 3.07 0.193*
Axial length (mm) 23.96 ± 1.18 24.03 ± 1.23 0.597*
Central corneal thickness (µm) 534.46 ± 26.76 540.14 ± 43.53 0.658*
Baseline IOP (mmHg) 14.2 ± 2.06 13.39 ± 1.00 0.469*
Baseline vertical cup-to-disc ratio 0.41 ± 0.14 0.64 ± 0.21  < 0.001*
Mean cpRNFL thickness (µm) 101.91 ± 11.47 78.57 ± 18.52  < 0.001*
Mean deviation (dB) 0.22 ± 5.14 -8.94 ± 8.47  < 0.001*
Glaucoma severity, n (%) Mild:14 (40)
Moderate: 14 (40)
Advanced: 7 (20)
Severe: 0 (0)

Values are presented as the mean ± standard deviation or number (%).

*Student t-test, † Chi-square test.

ACEI = angiotensin-converting enzyme inhibitor; BRB = beta receptor blocker; CCB = calcium channel blocker; cpRNFL = circumpapillary retinal nerve fiber layer.